KPower Healthcare chief executive officer Muhamad Badzli Abu Bakar said the company hopes to conclude the deal for three to five of the hospitals this year. KPower Healthcare was just set up in 2019 and the progress has been quite limited due to the Movement Control Order.
He also said the acquisition of international hospitals in Indonesia is in planning stages, with proposals for around 11 hospitals. In the current year, he expects to close (with the acquisition of) three to five hospitals in Indonesia.
In addition, he said that the company has also applied for a license to operate a hospital in Riyadh, Saudi Arabia, last month. KPower Healthcare is now talking to various parties, including public-listed companies and state governments such as Penang and Kelantan, for potential collaborations to develop hospitals in Malaysia.
KPower Bhd, which is mainly involved in sustainable energy and utilities activities, ventured into the healthcare industry early last year by acquiring 70% equity interest in BioNexus-status company Granulab, which also manufactures the granular synthetic bone graft GranuMas.
The newly launched Prosteomax, an innovative calcium phosphate-based synthetic bone cement, has been certified halal by the Malaysian Islamic Development Department (Jakim) and registered with the Malaysia Medical Device Authority for orthopedics, cranio, dental and maxillofacial applications.